STATE AFFAIRS

State of Nebraska

LB1017 prevents insurance companies from establishing specialty tiers to cover biologics, plasma-derived therapies and their recombinants, and other expensive therapies. This practice causes patients from paying copays for therapies to coinsurance which can be from 10% to 50% of the cost of the therapy. Most patients cannot afford to pay for these costs leaving them without their lifesaving therapies.

• Summary
• Copy of Bill
• Sample Letter of Support
• List of Members of the NE Senate Banking, Commerce and Insurance Committee and contact information to send letter of support.
• LB1018 News Report Videos

LB1088 – Physician and Patient Prescription Protection Act which requires that if a physician’s prescription is to be filled with a different brand, that a written communication be sent to the physician and patient notifying the change in prescription and reasons why.  For many patients, who are on certain brands, substituting the product can be life-threatening and in many cases, the physician and patient are not consulted prior to the switch.  This legislation will prevent the practice of switch without notification and ensure the safety of the patient.

• Summary
• Copy of Bill
• Sample Letter of Support
• List of Members of the NE Senate Banking, Commerce and Insurance Committee and contact information to send letter of support.